Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2014
08/19/2014US8808743 Benzonatate compositions and methods of use
08/19/2014US8808742 Compositions and methods for preparing and using same
08/19/2014US8808741 Tamper resistant dosage forms
08/19/2014US8808740 Encased tamper resistant controlled release dosage forms
08/19/2014US8808739 Orodispersible tablet containing compacted sildenafil base
08/19/2014US8808738 Aliphatic amine polymer salts for tableting
08/19/2014US8808737 Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment
08/19/2014US8808736 Enteric coated multiparticulate controlled release peppermint oil composition and related methods
08/19/2014US8808735 Fast wet-massing method for the preparation of calcium-containing compositions
08/19/2014US8808734 Cannabinoid formulations
08/19/2014US8808733 Method of controlled drug release from a liposome carrier
08/19/2014US8808732 Film forming personal care compositions and methods
08/19/2014US8808731 Adhesive pharmaceutical preparation containing bisoprolol
08/19/2014US8808729 Multilayered transmucosal therapeutic system
08/19/2014US8808725 Solid forms for tissue repair
08/19/2014US8808718 Hypertonic organic acid or salt thereof disinfectant composition and its use in dental treatment
08/19/2014US8808716 Topical foam composition
08/19/2014US8808715 Methods and compositions for modulating keratinocyte function
08/19/2014US8808714 Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics
08/19/2014US8808713 Compositions for pulmonary delivery of long-acting β2 adrenergic receptor agonists and associated methods and systems
08/19/2014US8808687 Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same
08/19/2014US8808669 Gastroretentive, extended release composition of therapeutic agent
08/19/2014US8808664 Lipidated glycoprotein particles and methods of use
08/19/2014US8808276 Adaptive dispensation in a digestive tract
08/19/2014US8808268 Method and composition for hyperthermally treating cells
08/19/2014US8808257 Methods and apparatus for pulsatile release of medicaments from a punctal plug
08/19/2014US8808219 Implant delivery device and methods thereof for treatment of ocular disorders
08/19/2014US8807979 Machine for the manufacture of dosage forms utilizing radiofrequency energy
08/19/2014CA2760555C Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
08/19/2014CA2717494C Compressed tablets
08/19/2014CA2691571C An inhalable composition
08/19/2014CA2646289C Wound dressings with anti-microbial and zinc-containing agents
08/19/2014CA2642479C A gastro-retentive system for the delivery of macromolecules
08/19/2014CA2637874C Patch and adhesive preparation
08/19/2014CA2626881C Biodegradable particle and production method thereof
08/19/2014CA2609579C Stable liquid desoximetasone compositions with reduced oxidized impurity
08/19/2014CA2596529C Hydrophilic biocompatible adhesive formulations and uses
08/19/2014CA2574437C Infusion and injection solution of levodopa
08/19/2014CA2569968C Controlled release matrix pharmaceutical dosage formulation
08/19/2014CA2565221C Biodegradable intravitreal tyrosine kinase inhibitors implants
08/19/2014CA2514294C Medical data communication notification and messaging system and method
08/19/2014CA2434409C Amphiphilic derivatives for the production of vesicles, micelles and complexants, and precursors thereof
08/19/2014CA2426200C Inhibition or reversal of skin aging by actin-sequestering peptides
08/14/2014WO2014124304A1 System and method using precious-metal nanoparticle contrast agent for microwave medical imaging
08/14/2014WO2014124151A1 Methods for rapidly treating severe hypoglycemia
08/14/2014WO2014124132A1 Stable pharmaceutical composition of clopidogrel free base for oral and parenteral delivery
08/14/2014WO2014124096A1 Stable glucagon formulations
08/14/2014WO2014123977A1 Geranylgeranylacetone formulations
08/14/2014WO2014123899A1 Tamper resistant pharmaceutical formulations
08/14/2014WO2014123500A1 Pharmaceutical formulations comprising cefpodoxime proxetil and clavulanic acid
08/14/2014WO2014123355A1 Orally administered celecoxib composition
08/14/2014WO2014123244A1 Solid dispersion comprising amorphous cilostazol
08/14/2014WO2014122586A1 Oral pharmaceutical composition of aliphatic amine polymer or salts thereof
08/14/2014WO2014122585A1 A stable pharmaceutical composition of amlodipine and benazepril or salts thereof
08/14/2014WO2014122563A1 An intra vaginal device, and a method of reducing the rate of diffusion of active ingredients in said intra vaginal device
08/14/2014WO2014122460A2 Pemetrexed complexes and pharmaceutical compositions containing pemetrexed complexes
08/14/2014WO2014122444A1 Permeation enhanced active-carrying nanoparticles
08/14/2014WO2014122436A1 Topical pharmaceutical compositions comprising minoxidil
08/14/2014WO2014122248A1 Kit-of-parts
08/14/2014WO2014122232A1 Pharmaceutical compositions comprising vesicles
08/14/2014WO2014122195A1 Pharmaceutical compositions incorporating low-dose drugs
08/14/2014WO2014122024A1 Topical antifungal composition for treating onychomycosis
08/14/2014WO2014121378A1 Conductive biomaterial for enhancement of conduction in vitro and in vivo
08/14/2014WO2014121342A1 Methods of treating topical microbial infections
08/14/2014WO2014104989A8 Pharmaceutical compositions comprising aripiprazole
08/14/2014WO2014096440A3 Albumin composition for preventing and/or reducing formation of peptide fibrils
08/14/2014WO2013111100A9 Stable amorphous raltegravir potassium premix and process for the preparation thereof
08/14/2014US20140228747 Recessed Bolus
08/14/2014US20140228444 Otic composition for companion animals
08/14/2014US20140228437 Pharmaceutical composition
08/14/2014US20140228430 Method of Accelerating Corneal Wound Healing
08/14/2014US20140228397 Propellant-free aerosol formulation for inhalation
08/14/2014US20140228390 Pharmaceutical Formulation Containing Gelling Agent
08/14/2014US20140228389 Dry powder compound formulations and uses thereof
08/14/2014US20140228354 Method for Inhibition of Deubiquitinating Activity
08/14/2014US20140228335 Ulipristal Acetate Tablets
08/14/2014US20140228287 1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-piperidin-1-yl]-axanthine for the treatment of a metabolic disorder of a predominantly carnivorous non-human animal
08/14/2014US20140228280 Low impurity content caspofungin preparation, method for preparing same, and use thereof
08/14/2014US20140227366 Carrier material for improving the persistance of biocides
08/14/2014US20140227364 Methods of manufacturing bioactive gels from extracellular matrix material
08/14/2014US20140227360 Stable pharmaceutical composition of clopidogrel free base for oral and parenteral delivery
08/14/2014US20140227358 Organic compounds
08/14/2014US20140227357 Fill formulations and capsules and method of use to avoid migration of fill into or through the shell
08/14/2014US20140227356 Composite formulation comprising a tablet encapsulated in a hard capsule
08/14/2014US20140227351 Taste masked pharmaceutical composition
08/14/2014US20140227349 Vesicle Compositions
08/14/2014US20140227348 Peptides that target dorsal root ganglion neurons
08/14/2014US20140227345 Components for producing amphoteric liposomes
08/14/2014US20140227343 Method of monitoring the release from liposomes of a product of interest using superparamagnetic nanoparticles
08/14/2014US20140227340 Fibers Comprising Poorly Soluble Drugs and/or Proteins
08/14/2014US20140227339 Regenerative tissue grafts and methods of making same
08/14/2014US20140227330 Capsule whose envelope is separately imperceptible during the topical use thereof
08/14/2014US20140227327 Injectable Cryogel Vaccine Devices and Methods of Use Thereof
08/14/2014US20140227326 Method of delivering nasal spray
08/14/2014US20140227318 Sleep quality improving agent
08/14/2014US20140227274 Prevention and Treatment of Amyloidogenic Disease
08/14/2014US20140227199 Penetrating pharmaceutical foam
08/14/2014US20140227197 Compositions for Treatment of Attention Deficit Hyperactivity Disorder
08/14/2014US20140227194 Preparation for Restenosis Prevention
08/14/2014US20140227193 Preparation for Restenosis Prevention
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 2991